94670-41-4

Basic information

• Product Name: (S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
• CAS NO: 94670-41-4
• Molecular Weight: 444.531
• Mol File: 94670-41-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(94670-41-4)
• EPA Substance Registry System: (S)-1-[(S)-2-((S)-2-tert-Butoxycarbonylamino-1-cyano-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(94670-41-4)

Safety Data

• Hazardous Substances Data: 94670-41-4(Hazardous Substances Data)

Upstream product

• 13485-59-1 L-alanyl-L-proline 
• 72155-45-4 Boc-L-phenylalaninal 
• 151-50-8 potassium cyanide 

Downstream Products

• 94706-12-4 N-<1-carbomethoxy-2-<(tert-butoxycarbonyl)amino>-3-phenylpropyl>-Ala-Pro-OCH3 
• 94798-96-6 N-<1-carbomethoxy-2-<(tert-butoxycarbonyl)amino>-3-phenylpropyl>-Ala-Pro-OCH3 
• 94670-44-7 N-(2-benzamido-1-carbomethoxy-3-phenylpropyl)-Ala-Pro-OCH₃ 
• 94730-86-6 N-(2-benzamido-1-carbomethoxy-3-phenylpropyl)-Ala-Pro-OCH₃ 
• 94730-82-2 N-(2-benzamido-1-carboxy-3-phenylpropyl)-Ala-Pro 
• 94730-83-3 N-(2-benzamido-1-carboxy-3-phenylpropyl)-Ala-Pro 
• 94670-43-6 (S)-1-[(S)-2-((1S,2S)-2-Amino-1-methoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid methyl ester 
• 94670-43-6 (S)-1-[(S)-2-((S)-2-Amino-1-methoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid methyl ester 
• 94670-42-5 N-<1-carboxamido-2-<(tert-butoxycarbonyl)amino>-3-phenylpropyl>-Ala-Pro-OCH3 

Relevant articles and documents

Angiotensin-converting enzyme inhibitors: Synthesis and biological activity of acyl tripeptide analogues of enalapril

The synthesis and biological activity of a series of inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) are described. Incorporation of the substituted N-carboxymethyl dipeptide design of enalapril (MK-421) into acyl tripeptides and larger peptides